Whole Exome Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
The whole exome sequencing market has been expected to reach a valuation of US$ 4,256.30 Mn and expand at a CAGR of 19.24% in the foreseeable years from 2020 to 2030.
The growth opportunities in the whole exome sequencing market are attributed to increasing application of the market services in the clinical diagnostics. In addition to this, increased expenditure on the R & D activities related to genomics, growing demand for rare diseases diagnosis, and rising need to customize the medicine are also serving as the crucial factors to bolster revenue generation opportunities in the whole exome sequencing market.
The key companies serving in the whole exome sequencing market are making investments across research-based projects. They are also establishing alliances with research centers for the delivery of drugs. Along with these initiatives, growing inclination toward the methods for next-generation sequencing to identify, treat, and monitor chronic diseases have also been projected to boost revenue generation opportunities in the whole exome sequencing market.
Continuous research on rare diseases or disorders and availability of the novel sequencing systems, software, and kits have also been contributing to the expansion opportunities in the whole exome sequencing market in the coming years.
Whole exome sequencing is expected to receive a staggering demand as DNA sequencing and its advances pave the way in the research field with the transformation of genomics. When compared with whole genome sequencing, whole exome sequencing is technically studied to be quick and cost-efficient. Since exons carry an 85.0% of disease traits, exome sequencing is regarded to be more effective. Researchers are anticipated to significantly adopt whole exome sequencing services, kits, and systems because of their double benefit of saving time and simplifying work.
On the basis of end user, the global whole exome sequencing market could gain a telling demand because of the influence of a colossal growth of government and academic institutions and research centers in the past. By application, the diagnostics segment is prognosticated to own a larger share in the global whole exome sequencing market. Predicted to incorporate two sub-segments, viz. data analysis and sequencing services, the services segment is prophesied to demonstrate dominance in the global whole exome sequencing market by products and services.
One of the high impression driving factors of the global whole exome sequencing market is the need to monitor pathogenic infections, cancer, and various other chronic maladies. More opportunities are envisaged to take birth with the surging adoption of next-generation sequencing techniques for the purpose of predicting and treating such diseases. The speed and cost factors are foretold to play a major role in the adoption of whole exome sequencing methods and the growth of the overall market.
Whole exome sequencing involves the sequencing of all protein-coding genes in a genome. Clinically exome account for 82% to 85% of known disease-causing variants and less than 1.5% to 2% of the human genome, which converts whole-exome sequencing into an effective alternative.
The report analyzes key market segments and growth trends in the past, based on which the progression analysis of the global market for whole exome sequencing for the 2020-2030 period is presented herein.
Technological progression in sequencing systems, collaborations and partnerships amongst leading research organizations for improved drug discovery, and an increasing expenditure on research and development are the major factors driving the global whole exome sequencing market. However, factors such as unavailability of trained workforce, increasing trend of funds and grants from universities and research organizations, and high instrument costs are challenging the growth of this market.
North America, Europe, Asia Pacific, and Rest of the World are the regional segments of the whole exome sequencing market. Amongst these, North America stands as the largest whole exome sequencing market. This is mainly due to the increasing application of whole exome sequencing for detection of rare diseases, increasing awareness programs through industry meets and conferences, and government funding for whole exome sequencing studies. In 2010, as per the Centers for Disease Control and Prevention (CDC), approximately 1,148,200 persons above the age of 13 and more were diagnosed with HIV infection in the United States, including 207,600 individuals whose infections had not been diagnosed.
Europe is the second largest market for whole exome sequencing. This is because Europe is a leading region for the diagnostics and treatment of cancer and HIV diseases. As per the World Health Organization (WHO), Europe is home to almost one quarter of the world’s cancer patients with 3.2 million new patients diagnosed every year. In 2010, UNAIDS estimated that approximately 2.3 million people were living with HIV in Europe. The prevalence of HIV among adults varies from less than 0.2% of the population in Central Europe to more than 1% of the population in parts of Eastern Europe.
Asia Pacific and Rest of the World are expected to be lucrative markets for whole exome sequencing in the coming years. Increasing research and development initiatives and strategic expansion and acquisitions among research organizations in the emerging economies of Asia Pacific are favoring the growth of this regional market. The increasing impact of bioinformatics and biotechnology research in Latin America is anticipated to fuel the growth of whole exome sequencing market. An increasing number of patients diagnosed with HIV in the emerging economies of India, China, and Brazil will lead to significant growth of the whole exome sequencing market in these regions.
The report mentions top players in the whole exome sequencing market, namely Agilent Technologies, BGI, Eurofins Genomics, Macrogen Inc., GENEWIZ Inc., Ambry Genetics, Illumina Inc., Thermo Fisher Scientific Inc., Roche NimbleGen Inc., Sengenics, and Knome Inc. among others.
The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.
TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report